Use of cancer screening services in Greece and associated social factors: Results from the nation-wide Hellas Health I survey

European Journal of Cancer Prevention

Volumn 18, Issue 3, 2009, Pages 248-257

  Dimitrakaki, Christine ^a   Boulamatsis, Dimitris ^b   Mariolis, Anargiros ^c   Kontodimopoulos, Nick ^d   Niakas, Dimitris ^d   Tountas, Yannis ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Metron Analysis   (Greece)

^c Health Centre of Vyronas   (Greece)

^d HELLENIC OPEN UNIVERSITY   (Greece)

Author keywords

Cancer screening; Digital rectal examination; Faecal occult blood test; Greece; Mammography; Papanicolaou smear test; Prostate specific antigen test; Social determinants

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; COLON CANCER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIGITAL RECTAL EXAMINATION; EDUCATION; FEMALE; GREECE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MARRIAGE; MULTIVARIATE ANALYSIS; OCCULT BLOOD; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; PUBLIC HEALTH; SOCIAL ASPECT; SOCIAL CLASS; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; GREECE; HEALTH SURVEYS; HUMANS; MALE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PROSTATIC NEOPLASMS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 68049127669     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32832405d6     Document Type: Article

References (53)

1. Aaronson LS, Burman ME (1994). Use of health records in research: reliability and validity issues. Res Nurs Health 17:67-73.
2. Advisory Committee on Cancer Prevention (2000). Recommendations on cancer screening in the European union. Eur J Cancer 36:1473-1478.
3. Anttila A, Ronco G, Clifford G, Hakama BF, Arbyn M, Weiderpass E (2004). Cervical cancer screening programmes and policies in 18 European countries. British Journal of Cancer 91:935-941.
4. Borràs JM, Guillen M, Sánchez V, Juncà S, Vicente R (1999). Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev 8:427-434.
5. Boyle P, d'Onofrio A, Maisonneuve P, Severi G, Robertson C, Tubiana M, Veronesi U (2003). Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? Ann Oncol 14:1312-1325.
6. Cabeza E, Esteva M, Pujol A, Thomas V, Sánchez-Contador C (2007). Social disparities in breast and cervical cancer preventive practices. Eur J Cancer Prev 16:372-379.
7. Chamot E, Charvet AI, Perneger TV (2007). Who gets screened, and where: a comparison of organized and opportunistic mammography screening in Geneva, Switzerland. Eur J Cancer 43:576-584.
8. Chiu LF (2003). Inequalities of access to cancer screening. A literature review. Cancer Screening Series No 1, NHS Cancer Screening Programmes, Sheffield, UK.
9. Ciatto S, Zappa M, Villers A, Paez A, Otto SJ, Auvinen A (2003). Contamination by opportunistic screening in the European Randomized Study of Prostate Cancer Screening. BJU Int 92 (Suppl 2):97-100.
10. Coleman MP, Alexe DM, Albreht T, McKee M (2008.) Responding to the challenge of cancer in Europe. European Observatory on Health Systems and Policies. Brussels. BEL, Institute of Public Health of the Republic of Slovenia, Ljubljana.
11. Dillner L, Pagliusi S, Bray F, Lorincz A, Kjaer SK, Anttila A, et al. (2008). Srengthening prevention programs to eliminate cervical cancer in the Nordic countries. Acta Obstet Gynecol Scand 87:489-498.
12. Duport N, Ancelle-Park R (2006). Do socio-demographic factors influence mammography use of French women? Analysis of a French cross-sectional survey. Eur J Cancer Prev 15:219-224.
13. Esomar (1997). Standard demographic segmentation. A system of international socio-economic classification of respondents to survey research. www.esomar.org
14. Gattellari M, Young JM, Ward JE (2003). GP and patient predictors of PSA screening in Australian general practice. Family Practice 20:294-303.
15. George SA (2000). Barriers to breast cancer screening: an integrative review. Health Care Women Int 21:53-65.
16. Giorgi D, Giordano L, Ventura L, Puliti D, Piccini P, Eugenio P (2006). Mammography screening in Italy: 2003-2004 survey. Epidemiol Prev 30 (1 Suppl 3):7-16.
17. Hakama M, Coleman MP, Alexe DM, Auvinen A (2008). Cancer screening: Evidence and practice in Europe. Eur J Cancer 44:1404-1413. doi:10.1016/j.physletb.2003.10.071.
18. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J (2000). The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess 4:1-133.
19. Kamposioras K, Davide M, Golfinopoulos V, Ferentinos G, Zacharias G, Xilomenos A, et al. (2007). Colorectal cancer screening coverage in Greece. PACMeR 02.01 study collaboration. Int J Colorectal Dis 22:475-481.
20. Katz SJ, Hofer TP (1994). Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA 272:530-534.
21. Keighley M (2004). Raising awareness on colorectal screening in Europe. Cancer Futures 3:103-106.
22. Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M (2002). Sociodemographic predictors of non-attendance at invitational mammography screening - a population-based register study (Sweden). Canc Causes Contr 13:73-82.
23. Lagerlund M, Sparén P, Thurfjell E, Ekbom A, Lambe M (2000). Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev 9:25-33.
24. Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer BK (2002). The effectiveness of interventions to promote mammography among women with historically lower rates of screening. Cancer Epidemiol Biomarkers Prev 11:59-71.
25. Linos A, Riza E (2000). Comparisons of cervical cancer screening programmes in the European Union. Eur J Cancer 36:2260-2265.
26. Lorant V, Boland B, Humblet P, Deliège D (2002). Equity in prevention and health care. J Epidemiol Community Health 56:510-516.
27. Madlensky L, Goel V, Polzer J, Ashbury FD (2003). Assessing the evidence for organised cancer screening programmes. Eur J Cancer 39:1648-1653.
28. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. (2003). European health systems and cancer care. Ann Oncol 14 (Suppl 5): 41-60.
29. Miller AB (2002). The (in)efficiency of cervical screening in Europe. Eur J Cancer 38:321-326.
30. Molassiotis A (2006). Disparities in cancer care in Europe. Eur J Oncol Nurs 10:167-168.
31. Mossialos E, Allin S, Davaki K (2005). Analysing the Greek health system: a tale of fragmentation and inertia. Health Econ 14 (Suppl 1):151-168.
32. Mousiama T, Loakimidou S, Largatzi E, Kaitelidou D, Liaropoulus L (2001). Health technology assessment in the area of prevention: selected screening cases in Greece. Int J Technol Assess Health Care 17:338-357.
33. Newell SA, Girgis A, Sanson-Fisher RW, Savolainen NJ (1999). The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population: a critical review. Am J Prev Med 17:211-229.
34. Nieminen P, Kallio M, Anttila A, Hakama M (1999). Organised vs. spontaneous Pap-smear screening for cervical cancer: a case-control study. Int J Cancer 83:55-58.
35. Perry N, Broeders M, de Wolf C, Törnberg S, Holland L, von Karsa H (2006). European guidelines for quality assurance in breast cancer screening and diagnosis. Luxembourg: Office for Official Publications of the European Communities.
36. Petersen GM (2002). Barriers to preventive intervention. Gastroenterol Clin North Am 31:1061-1068.
37. Primic-Zakelj M, Repse-Fokter A (2007). Cervical cancer screening: a Slovenian experience. Coll Antropol 31 (Suppl 2):23-26.
38. Quinn M, Babb P, Jones J, Allen E (1999). Effect of screening on incidence of and mortality from cancer of the cervix in England: evaluation based on routinely collected statistics. BMJ 318:904-911.
39. Rauscher GH, Johnson TP, Cho YI, Walk JA (2008). Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 17:748-757.
40. Rimer BK, Resch N, King E, Ross E, Lerman C, Boyce A, et al. (1992). Multistrategy health education program to increase mammography use among women aged 65 and older. Public Health Rep 107:369-380.
41. Riza E, Kyriakogianni-Psaropoulou P, Koumantakis E, Symiakaki H, Garas I, Linos A (2000). Cervical cancer screening in Greece. Eur J Cancer 36:2227-2232.
42. Robin KY, Mangan P, Mandelblatt J (2003). Effectiveness of interventions to increase papanicolaou smear use. J Am Board Fam Pract 16:188-203.
43. Sabates R, Feinstein L (2006). The role of education in the uptake of preventative health care: the case of cervical screening in Britain. Soc Sci Med 62:2998-3010.
44. Sánchez V, Rohlfs I, Borràs JM, Borrell C (1997). Migration within Spain, level of education, and cervical cancer screening. Eur J Cancer Prev 6:31-37.
45. Sarkeala T, Heinävaara S, Anttila A (2008). Breast cancer mortality with varying invitational policies in organized mammography. Br J Cancer 98:641-645.
46. UK Colorectal Cancer Screening Pilot Group (2004). Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 329:133.
47. Vernon SW (1997). Participation in colorectal cancer screening: a review. J Natil Cancer Inst 89:1406-1422.
48. Vernon SW, Briss PA, Tiro JA, Warnecke RB (2004). Some methodologic lessons learned from cancer screening research. Cancer 101 (5 Suppl): 1131-1145.
49. Von Euler-Chelpin M, Olsen AH, Njor S, Vejborg I, Schwartz W, Lynge E (2008). Socio-demographic determinants of participation in mammography screening. Int J Cancer 122:418-423.
50. Wittink MN, Bogner HR (2008). Primary care physicians' assessments of older patients' health and psychological status and recommendation of mammography. J Am Board Fam Pract 21:17-23.
51. Xilomenos A, Mauri D, Kamposioras D, Gkinosati A, Zacharias G, Sidiropoulou V, et al., for Panhellenic Association for Continual Medical Research (PACMeR) (2006). Colorectal cancer screening awareness among physicians in Greece. BMC Gastroenterol 6:18.
52. Zacharias G, Xilomenos A, Koukourakis G, Kamposioras K, Mauri D, Chasioti D, et al. (2008). Responsibilities in cancer preventive care in Greece. A physicians' survey. Clin Transl Oncol 10:231-234.
53. Zarychanski R, Chen Y, Bernstein CN, Hébert PC (2007). Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ 177:593-597.